eHealth (EHTH) 10-Q 8 May 15 2015 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2015	1-May-15
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Trading Symbol	EHTH
Entity Registrant Name	eHealth, Inc.
Entity Central Index Key	1333493
Current Fiscal Year End Date	-19
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		17,908,942

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$39,365	$51,415
Accounts receivable	14,614	8,200
Deferred income taxes	386	386
Prepaid expenses and other current assets	7,052	6,474
Total current assets	61,417	66,475
Property and equipment, net	8,944	9,640
Other assets	3,875	5,679
Intangible assets, net	10,429	10,774
Goodwill	14,096	14,096
Total assets	98,761	106,664
Current liabilities:
Accounts payable	2,303	5,961
Accrued compensation and benefits	8,222	8,204
Accrued marketing expenses	1,551	8,707
Deferred revenue	882	869
Accrued restructuring charges	1,436	0
Other current liabilities	4,752	2,996
Total current liabilities	19,146	26,737
Non-current liabilities	6,650	6,449
Stockholders’ equity:
Common stock	29	29
Additional paid-in capital	260,575	259,007
Treasury stock, at cost	-199,998	-199,998
Retained earnings	12,179	14,261
Accumulated other comprehensive income	180	179
Total stockholders’ equity	72,965	73,478
Total liabilities and stockholders’ equity	$98,761	$106,664

Condensed_Consolidated_Stateme

Condensed Consolidated Statements Of Comprehensive Income (Loss) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Revenue
Commission	$57,819	$45,577
Other	3,469	5,363
Total revenue	61,288	50,940
Operating costs and expenses:
Cost of revenue	2,414	2,113
Marketing and advertising	25,451	23,109
Customer care and enrollment	11,861	9,713
Technology and content	10,773	10,467
General and administrative	7,973	8,294
Restructuring charges	4,483	0
Amortization of intangible assets	345	354
Total operating costs and expenses	63,300	54,050
Loss from operations	-2,012	-3,110
Other expense, net	-14	-39
Loss before provision for income taxes	-2,026	-3,149
Provision (benefit) for income taxes	56	-1,596
Net loss	-2,082	-1,553
Foreign currency translation adjustment	1	16
Comprehensive loss	($2,081)	($1,537)
Net income (loss) per share:
Basic (in usd per share)	($0.12)	($0.08)
Diluted (in usd per share)	($0.12)	($0.08)
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic (in shares)	17,844	18,849
Diluted (in shares)	17,844	18,849

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements Of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Operating activities
Net loss	($2,082)	($1,553)
Adjustments to reconcile net loss to net cash used in operating activities:
Deferred income taxes	0	-1,608
Depreciation and amortization	1,058	999
Amortization of book-of-business consideration	1,962	1,574
Amortization of intangible assets	345	354
Stock-based compensation expense	2,031	2,445
Deferred rent	27	8
Changes in operating assets and liabilities:
Accounts receivable	-6,400	-3,800
Prepaid expenses and other assets	-736	-3,496
Accounts payable	-3,658	-1,973
Accrued compensation and benefits	16	-1,385
Accrued marketing expenses	-7,156	3,181
Deferred revenue	-152	-382
Accrued restructuring charges	1,771	0
Other current liabilities	1,802	226
Net cash used in operating activities	-11,172	-5,410
Investing activities
Purchases of property and equipment	-384	-1,115
Purchase of intangible assets	0	-4,500
Net cash used in investing activities	-384	-5,615
Financing activities
Net proceeds from exercise of common stock options	0	2,283
Cash used to net-share settle equity awards	-480	-3,304
Excess tax benefits from stock-based compensation	0	3,220
Principal payments in connection with capital leases	-19	-13
Net cash provided by (used in) financing activities	-499	2,186
Effect of exchange rate changes on cash and cash equivalents	5	12
Net decrease in cash and cash equivalents	-12,050	-8,827
Cash and cash equivalents at beginning of period	51,415	107,055
Cash and cash equivalents at end of period	$39,365	$98,228

Summary_Of_Business_And_Signif

Summary Of Business And Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Summary Of Business And Significant Accounting Policies	Note 1 - Summary of Business and Significant Accounting Policies
	Description of Business—eHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading private online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (www.eHealth.com,  www.eHealthInsurance.com,  www.eHealthMedicare.com, www.Medicare.com and www.PlanPrescriber.com), consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all 50 states and the District of Columbia.
	Basis of Presentation—The accompanying condensed consolidated balance sheet as of March 31, 2015, the condensed consolidated statements of comprehensive loss for the three months ended March 31, 2014 and 2015 and the condensed consolidated statements of cash flows for the three months ended March 31, 2014 and 2015, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2014 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014, which was filed with the Securities and Exchange Commission on March 16, 2015. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K.
	The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2014, and include all adjustments necessary for the fair presentation of eHealth’s statement of financial position as of March 31, 2015, its results of operations for the three months ended March 31, 2014 and 2015 and its cash flows for the three months ended March 31, 2014 and 2015. All adjustments are of a normal recurring nature. The results for the three months ended March 31, 2015 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December 31, 2015.
	Seasonality—The majority of our individual and family plans are sold in the open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. In the fourth quarter of 2014 and the first quarter of 2015, during the second open enrollment period that began on November 15, 2014 and ended on February 15, 2015, the number of individual and family applications submitted increased compared to periods outside of the open enrollment period. In the fourth quarter of 2013 and first quarter of 2014, there was a significant increase, relative to historical levels, in the number of individual and family applications submitted during the initial open enrollment period, that began on October 1, 2013 and ended on March 31, 2014.
	The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, historically we recognized a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies renewed on January 1 of each year. This trend continued and became more pronounced in 2015 due to Centers for Medicare and Medicaid Services ("CMS"), regulations that changed the definition of a plan year from being twelve months from the effective date of a policy to January 1 through December 31 of each year, causing all Medicare Advantage and Medicare Part D prescription drug policies to renew on January 1 of each year.
	Since a significant portion of our marketing and advertising expenses consists of expenses incurred in search engine advertising at the time a consumer clicks on an advertisement and payments owed to our marketing partners in connection with health insurance applications submitted on our ecommerce platform, those expenses are influenced by seasonal submitted application patterns. As a result of the second open enrollment period for individual and family health insurance that began on November 15, 2014 and ended on February 15, 2015, marketing and advertising expenses increased during the fourth quarter of 2014 and first quarter of 2015, consistent with the increases in submitted applications, compared to periods outside the open enrollment period. In addition, due to the initial open enrollment period for individual and family health insurance that began in October 2013 and ended on March 31, 2014, marketing and advertising expenses increased significantly in the fourth quarter of 2013 and first quarter of 2014, relative to historical levels, and decreased significantly during the second and third quarters of 2014, consistent with the respective increases and decreases in submitted applications.
	In the first quarter of 2015, the first and fourth quarters of 2014 and the fourth quarter of 2013, we incurred a net loss due in part to our higher marketing and advertising expenses associated with the individual and family health insurance applications during the open enrollment periods for individual and family health insurance and Medicare related health insurance applications during the Medicare annual enrollment periods without a commensurate level of additional revenue resulting from those applicants during the enrollment periods. Conversely, in both the second and third quarters of 2014, we recorded net income due to significantly lower marketing and advertising expenses associated with the decrease in the number of individual and family health insurance applications outside of the open enrollment period and increased revenue resulting from members who submitted applications during the open enrollment period in the prior respective quarters.
	Recent Accounting Pronouncements—In February 2015, the FASB issued Accounting Standards Update No. 2015-02 (ASU 2015-02) "Consolidation (Topic 810): Amendments to the Consolidation Analysis." ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. It is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We are currently in the process of evaluating the impact of the adoption of ASU 2015-02 on our consolidated financial statements.
	In April 2015, the FASB issued Accounting Standards Update No. 2015-05 (ASU 2015-05), "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement." ASU 2015-05 provides guidance to clarify the customer’s accounting for fees paid in a cloud computing arrangement. It is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We are currently in the process of evaluating the impact of the adoption of ASU 2015-05 on our consolidated financial statements.

Balance_Sheet_Accounts

Balance Sheet Accounts	3 Months Ended
	Mar. 31, 2015
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Accounts	Note 2 – Balance Sheet Accounts
	Cash and Cash Equivalents—As of December 31, 2014 and March 31, 2015, our cash equivalents consisted of money market accounts that invested in U.S. government-sponsored enterprise bonds and discount notes, U.S. government treasury bills and notes and repurchase agreements collateralized by U.S. government obligations. At December 31, 2014 and March 31, 2015, our cash equivalents carried no unrealized gains or losses and we did not realize any significant gains or losses on sales of cash equivalents during the three months ended March 31, 2014 and 2015.
	As of December 31, 2014 and March 31, 2015, our cash and cash equivalent balances were invested as follows (in thousands):
		December 31, 2014		March 31, 2015
	Cash	$	15,793	$	14,742
	Money market funds	35,622		24,623
	Total cash and cash equivalents	$	51,415	$	39,365
	Our money market funds reflect unadjusted quoted prices in active markets for identical assets and are classified as Level 1 as of December 31, 2014 and March 31, 2015.
	Accounts Receivable—As of December 31, 2014 and March 31, 2015, our accounts receivable consisted of the following (in thousands):
		December 31, 2014		March 31, 2015
	Medicare renewal commission receivable	$	355	$	12,790
	Accounts receivable - from other revenues	2,462		1,329
	Other commissions receivable	5,383		495
	Total accounts receivable	$	8,200	$	14,614
	As a result of a regulation issued by CMS, which changed the definition of a plan year from being 12-months from the effective date of a policy to January 1 through December 31 of each year, all Medicare Advantage and Medicare Part D prescription drug policies will renew on January 1 of each year, resulting in our recording of all Medicare Advantage and Medicare Part D prescription drug plan renewal commission revenue in the first quarter of each year. We fully implemented this new rule in our first quarter ended March 31, 2015. We recognize a full year of renewal commission revenue at the time a policy is renewed, however, renewal commissions for Medicare Advantage products are paid monthly. As a result, the majority of renewal commissions for that product will be collected in quarters subsequent to the first quarter.

Stockholders_Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stockholders' Equity	Note 3 – Stockholders’ Equity
	Stock Plans—The following table summarizes activity under our 2014 Equity Incentive Plan, 2006 Equity Incentive Plan, 1998 Stock Plan and 2005 Stock Plan (collectively, the “Stock Plans”) (in thousands):
		Shares Available for Grant
	Shares available for grant December 31, 2014	4,164
	Restricted stock units granted	(200	)
	Restricted stock units cancelled (1)	19
	Options cancelled (2)	9
	Shares available for grant March 31, 2015	3,992
	-1	Restricted stock units cancelled does not include 9,000 restricted stock units cancelled under the 2006 Equity Incentive Plan.
	-2	Options cancelled does not include 116,000 stock options cancelled under the 2006 Equity Incentive Plan.
	We maintain our 2006 Equity Incentive Plan, 2005 Stock Plan and 1998 Stock Plan, under which we previously granted options to purchase shares of our common stock and restricted stock units. The 2006 Equity Incentive Plan was terminated with respect to the grant of additional awards on June 12, 2014, upon adoption of our 2014 Equity Incentive Plan. The 2005 Stock Plan and 1998 Stock Plan were terminated with respect to the grant of additional awards upon the effectiveness of the 2006 Equity Incentive Plan. We will continue to issue new shares of common stock upon vesting of restricted stock units and the exercise of stock options previously granted under the 2006 Equity Incentive Plan, 2005 Stock Plan and 1998 Stock Plan.
	The following table summarizes stock option activity under the Stock Plans (in thousands, except per share amounts and weighted average remaining contractual life data):
		Number of Stock Options			Weighted Average Exercise Price			Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (1)
	Balance outstanding at December 31, 2014	1,724			$	18.5		3.31	$	12,884
	Granted	—			$	—
	Exercised	—			$	—			$	—
	Cancelled	(125	)		$	22.66
	Balance outstanding at March 31, 2015	1,599			$	18.17		3.12	$	80
	Vested and expected to vest at March 31, 2015	1,571			$	18.08		3.09	$	80
	Exercisable at March 31, 2015	1,233			$	17.01		2.68	$	80
	-1	The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2014 and March 31, 2015 and the exercise price of in-the-money options as of those dates.
	The total fair value of stock options vested during the three months ended March 31, 2014 and 2015 was $0.6 million and $0.5 million, respectively.
	The following table summarizes restricted stock unit activity, including performance-based and market-based restricted stock unit activity, under the Stock Plans (in thousands, except per share amounts and weighted average remaining contractual life data):
		Number of Restricted Stock Units (1)			Weighted-Average Grant Date Fair Value			Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (2)
	Balance outstanding as of December 31, 2014	873			$	30.86		2.52	$	21,753
	Granted	200			$	6.69
	Vested	(124	)		$	17.95
	Cancelled	(28	)		$	30.56
	Balance outstanding as of March 31, 2015	921			$	27.37		2.93	$	8,642
	-1	Includes certain restricted stock units with both service and performance-based or market-based vesting criteria granted to our executive officers.
	-2	The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2014 and March 31, 2015 multiplied by the number of restricted stock units outstanding as of December 31, 2014 and March 31, 2015, respectively.
	The fair value of the restricted stock units is based on eHealth’s stock price on the date of grant, and compensation expense related to these awards is recognized on a straight-line basis over the vesting period. The fair value of performance-based restricted stock units is based on eHealth’s stock price on the date of grant, and compensation expense related to these awards is recognized on an accelerated basis over the vesting period. The amount of expense recorded for performance-based restricted stock units is based on expected attainment of performance criteria. The total fair value of restricted stock units vested during the three months ended March 31, 2014 and 2015 was $8.4 million and $1.2 million, respectively.
	Stock Repurchase Programs—We had no stock repurchase activity during the three months ended March 31, 2015. In addition to the shares repurchased under our past repurchase programs as of March 31, 2015, we have in treasury 327,947 shares that were previously surrendered by employees to satisfy tax withholdings due in connection with the vesting of certain restricted stock units. As of December 31, 2014 and March 31, 2015, we had a total of 10,945,607 shares and 10,991,835 shares, respectively, held in treasury.
	Stock-Based Compensation—In March 2015, we granted market-based stock unit awards to certain members of senior management. Each market-based stock unit award represents a contingent right to receive certain shares of the Company’s common stock upon the attainment of certain stock prices over a four-year performance period. Once a stock price threshold is achieved, the portion of the award related to that threshold will vest on the one-year anniversary of the date of achievement, subject to the employee's continued service through each vesting date. Compensation expense related to these awards is recognized on an accelerated basis over the requisite service period. The weighted-average fair value of the market-based stock unit awards was determined using the Monte Carlo simulation model incorporating the following weighted average assumptions:
		Three Months Ended March 31,
		2015
	Expected term	2.59 years
	Expected volatility	64.7		%
	Expected dividend yield	—		%
	Risk-free interest rate	1.13		%
	Weighted-average fair value	$	6.69
	The following table summarizes stock-based compensation expense recorded during the three months ended March 31, 2014 and 2015 (in thousands):
		Three Months Ended March 31,
		2014				2015
	Common stock options	$	642			$	462
	Restricted stock units	1,803				1,569
	Total stock-based compensation expense	$	2,445			$	2,031
	The following table summarizes stock-based compensation expense by operating function for the three months ended March 31, 2014 and 2015 (in thousands):
		Three Months Ended March 31,
		2014				2015
	Marketing and advertising	$	657			$	591
	Customer care and enrollment	96				117
	Technology and content	562				435
	General and administrative	1,130				775
	Restructuring charges	—				113
	Total stock-based compensation expense	$	2,445			$	2,031

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Note 4 – Income Taxes
	The following table summarizes our provision for income taxes and our effective tax rates for the three months ended March 31, 2014 and 2015 (in thousands, except effective tax rate):
		Three Months Ended March 31,
		2014			2015
	Income (loss) before provision for income taxes	$	(3,149	)	$	(2,026	)
	Provision (benefit) for income taxes	$	(1,596	)	$	56
	Effective tax rate	50.7		%	(2.8		)%
	Our effective tax rate in the three months ended March 31, 2014 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses. Our effective tax rate in the three months ended March 31, 2015 was lower than statutory federal and state tax rates due primarily to the change in valuation allowance, partially offset by certain discrete items.
	During the three months ended March 31, 2014, excess federal and state tax benefits related to share-based payments resulted in increases of $3.2 million in Additional Paid-In Capital in the condensed consolidated balance sheets. These amounts are also classified in the condensed consolidated statements of cash flows as both a reduction to operating cash flows and as a financing cash inflow. During the three months ended March 31, 2015, no excess federal and state tax benefits related to share-based payments were recognized.

Net_Income_Per_Share

Net Income Per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Net Income Per Share	Net Income (Loss) Per Share
	Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding for the period. Diluted net income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all potential dilutive common stock equivalent shares, including options and restricted stock units. The dilutive effect of outstanding awards is reflected in diluted net income (loss) per share by application of the treasury stock method.
	The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share amounts):
		Three Months Ended March 31,
		2014				2015
	Basic and diluted:
	Numerator:
	Net loss allocated to common stock	$	(1,553	)		$	(2,082	)
	Denominator:
	Weighted average number of common stock shares outstanding	18,849				17,844
	Net loss per share—basic and diluted:	$	(0.08	)		$	(0.12	)
	For each of the three month periods ended March 31, 2014 and 2015, we had securities outstanding that could potentially dilute net income per share, but the shares from the assumed exercise of these securities were excluded in the computation of diluted net loss per share as their effect would have been anti-dilutive. The number of outstanding weighted average anti-dilutive shares that were excluded from the computation of diluted net loss per share consisted of the following (in thousands):
		Three Months Ended March 31,
		2014			2015
	Common stock options	1,932			1,702
	Restricted stock units	745			618
	Total	2,677			2,320

Geographic_Information_And_Sig

Geographic Information And Significant Customers	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Geographic Information And Significant Customers	Note 6 – Geographic Information and Significant Customers
	Geographic Information—As of December 31, 2014 and March 31, 2015, our long-lived assets consisted primarily of property and equipment, goodwill and other indefinite-lived intangible assets and finite-lived intangible assets. Our long-lived assets are attributed to the geographic location in which they are located. Long-lived assets by geographical area were as follows (in thousands):
		As of			As of
		December 31, 2014			March 31, 2015
	United States	$	39,752		$	36,885
	China	437			459
	Total	$	40,189		$	37,344
	Significant Customers—Substantially all revenue for the three months ended March 31, 2014 and 2015 was generated from customers located in the United States. Carriers representing 10% or more of our total revenue in the three months ended March 31, 2014 and 2015 are presented in the table below:
		Three Months Ended March 31,
		2014		2015
	Humana	26	%	34	%
	WellPoint (1)	11	%	8	%
	UnitedHealthcare (2)	11	%	9	%
	Aetna (3)	11	%	9	%
	(1)Wellpoint also includes other carriers owned by Wellpoint.
	(2)UnitedHealthcare also includes other carriers owned by UnitedHealthcare.
	(3)Aetna also includes other carriers owned by Aetna.
	Commission revenue attributable to major medical individual and family health insurance plans was approximately 60% and 38% of our commission revenue in the three months ended March 31, 2014 and 2015, respectively. We define our individual and family plan offerings as major medical individual and family health insurance plans, which do not include small business, Medicare-related health insurance plan offerings and other ancillary products such as short-term, stand-alone dental, life, vision, and accident insurance plan offerings.
	As of December 31, 2014, three customers represented 30%, 17% and 14%, respectively, of our $8.2 million outstanding accounts receivable balance. As of March 31, 2015, two customers represented 62% and 10%, respectively, of our $14.6 million outstanding accounts receivable balance. No other customers represented 10% or more of our total accounts receivable at December 31, 2014 and March 31, 2015. We believe the potential for collection issues with any of our customers is minimal as of March 31, 2015. Accordingly, our estimate for uncollectible amounts at March 31, 2015 was not material.

Restructuring_Charges

Restructuring Charges	3 Months Ended
	Mar. 31, 2015
Restructuring and Related Activities [Abstract]
Restructuring Charges	Note 7 – Restructuring Charges
	In March 2015, we implemented an organizational restructuring and cost reduction plan designed to rebalance our resources and help reduce our cost structure as a result of lower than expected individual and family health insurance plan membership and revenue. As part of the plan, we eliminated 160 full-time positions in the United States, representing approximately 15% of our workforce primarily in our technology and content and customer care and enrollment groups, and to a lesser extent, in our marketing and advertising and general and administrative groups. We incurred pre-tax restructuring charges of approximately $3.9 million for employee termination benefits and related costs as well as $0.6 million in other pre-tax restructuring charges, primarily consisting of facility costs. The majority of the restructuring charges were recorded in the first quarter of 2015, when the activities comprising the plan were substantially completed. In March 2015, we also eliminated certain positions in our China operation.
	The following table summarizes the total cash and non-cash restructuring charges recorded during the three months ended March 31, 2015 (in thousands):
		Three Months Ended March 31, 2015
	Employee termination costs	$	3,734
	Non-cash employee termination costs - stock-based compensation	113
	Facility and other termination costs	636
	Total restructuring charges	$	4,483
	The following table summarizes the restructuring charges liability activity during the three months ended March 31, 2015 (in thousands):
		Three Months Ended March 31, 2015
		Beginning balance		Charges		Payments			Ending balance
	Employee termination costs	$	—	$	3,734	$	(2,567	)	$	1,167
	Facility and other termination costs	—		636		(33		)	603
	Total restructuring liability	$	—	$	4,370	$	(2,600	)	$	1,770
	Less: non-current restructuring charges associated with facilities								(334		)
	Restructuring charges liability - current								$	1,436

Commitments_and_Contingencies_

Commitments and Contingencies Commitments and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 8 - Commitments and Contingencies
	Legal Proceedings—On January 26 and March 10, 2015, two purported class action lawsuits were filed against us, our chairman of the board and chief executive officer, Gary L. Lauer (“Mr. Lauer”), and our senior vice president and chief financial officer, Stuart M. Huizinga (“Mr. Huizinga”), in the United States District Court for the Northern District of California.  The complaints allege that the defendants made false and misleading statements regarding our financial performance, guidance and operations during alleged class periods of October 31, 2014 to January 14, 2015 and June 5, 2014 to January 14, 2015, respectively.  The complaints allege that we and Messrs. Lauer and Huizinga violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.  The complaints seek compensatory damages, attorneys’ fees and costs, rescission or a rescissory measure of damages, equitable/injunctive relief and such other relief as the court deems proper.
	In the ordinary course of our business, we have received and may continue to receive inquiries from state regulators relating to various matters. At December 31, 2014 and March 31, 2015, we had no material liabilities included in our consolidated balance sheet for outstanding legal claims.

Summary_Of_Business_And_Signif1

Summary Of Business And Significant Accounting Policies (Policy)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Description Of Business	Description of Business—eHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading private online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (www.eHealth.com,  www.eHealthInsurance.com,  www.eHealthMedicare.com, www.Medicare.com and www.PlanPrescriber.com), consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all 50 states and the District of Columbia.
Basis Of Presentation	Basis of Presentation—The accompanying condensed consolidated balance sheet as of March 31, 2015, the condensed consolidated statements of comprehensive loss for the three months ended March 31, 2014 and 2015 and the condensed consolidated statements of cash flows for the three months ended March 31, 2014 and 2015, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2014 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014, which was filed with the Securities and Exchange Commission on March 16, 2015. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K.
	The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2014, and include all adjustments necessary for the fair presentation of eHealth’s statement of financial position as of March 31, 2015, its results of operations for the three months ended March 31, 2014 and 2015 and its cash flows for the three months ended March 31, 2014 and 2015. All adjustments are of a normal recurring nature. The results for the three months ended March 31, 2015 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December 31, 2015.
Seasonality	Seasonality—The majority of our individual and family plans are sold in the open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. In the fourth quarter of 2014 and the first quarter of 2015, during the second open enrollment period that began on November 15, 2014 and ended on February 15, 2015, the number of individual and family applications submitted increased compared to periods outside of the open enrollment period. In the fourth quarter of 2013 and first quarter of 2014, there was a significant increase, relative to historical levels, in the number of individual and family applications submitted during the initial open enrollment period, that began on October 1, 2013 and ended on March 31, 2014.
	The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, historically we recognized a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies renewed on January 1 of each year. This trend continued and became more pronounced in 2015 due to Centers for Medicare and Medicaid Services ("CMS"), regulations that changed the definition of a plan year from being twelve months from the effective date of a policy to January 1 through December 31 of each year, causing all Medicare Advantage and Medicare Part D prescription drug policies to renew on January 1 of each year.
	Since a significant portion of our marketing and advertising expenses consists of expenses incurred in search engine advertising at the time a consumer clicks on an advertisement and payments owed to our marketing partners in connection with health insurance applications submitted on our ecommerce platform, those expenses are influenced by seasonal submitted application patterns. As a result of the second open enrollment period for individual and family health insurance that began on November 15, 2014 and ended on February 15, 2015, marketing and advertising expenses increased during the fourth quarter of 2014 and first quarter of 2015, consistent with the increases in submitted applications, compared to periods outside the open enrollment period. In addition, due to the initial open enrollment period for individual and family health insurance that began in October 2013 and ended on March 31, 2014, marketing and advertising expenses increased significantly in the fourth quarter of 2013 and first quarter of 2014, relative to historical levels, and decreased significantly during the second and third quarters of 2014, consistent with the respective increases and decreases in submitted applications.
Recently Adopted Accounting Standards	Recent Accounting Pronouncements—In February 2015, the FASB issued Accounting Standards Update No. 2015-02 (ASU 2015-02) "Consolidation (Topic 810): Amendments to the Consolidation Analysis." ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. It is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We are currently in the process of evaluating the impact of the adoption of ASU 2015-02 on our consolidated financial statements.
	In April 2015, the FASB issued Accounting Standards Update No. 2015-05 (ASU 2015-05), "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement." ASU 2015-05 provides guidance to clarify the customer’s accounting for fees paid in a cloud computing arrangement. It is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We are currently in the process of evaluating the impact of the adoption of ASU 2015-05 on our consolidated financial statements.

Balance_Sheet_Accounts_Tables

Balance Sheet Accounts (Tables)	3 Months Ended
	Mar. 31, 2015
Balance Sheet Related Disclosures [Abstract]
Schedule Of Cash And Cash Equivalents	As of December 31, 2014 and March 31, 2015, our cash and cash equivalent balances were invested as follows (in thousands):
		December 31, 2014		March 31, 2015
	Cash	$	15,793	$	14,742
	Money market funds	35,622		24,623
	Total cash and cash equivalents	$	51,415	$	39,365
Schedule Of Accounts Receivable	Accounts Receivable—As of December 31, 2014 and March 31, 2015, our accounts receivable consisted of the following (in thousands):
		December 31, 2014		March 31, 2015
	Medicare renewal commission receivable	$	355	$	12,790
	Accounts receivable - from other revenues	2,462		1,329
	Other commissions receivable	5,383		495
	Total accounts receivable	$	8,200	$	14,614

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule Of Activity Under The Plans	The following table summarizes activity under our 2014 Equity Incentive Plan, 2006 Equity Incentive Plan, 1998 Stock Plan and 2005 Stock Plan (collectively, the “Stock Plans”) (in thousands):
		Shares Available for Grant
	Shares available for grant December 31, 2014	4,164
	Restricted stock units granted	(200	)
	Restricted stock units cancelled (1)	19
	Options cancelled (2)	9
	Shares available for grant March 31, 2015	3,992
Schedule Of Stock Option Activity Under Stock Plans	The following table summarizes stock option activity under the Stock Plans (in thousands, except per share amounts and weighted average remaining contractual life data):
		Number of Stock Options			Weighted Average Exercise Price			Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (1)
	Balance outstanding at December 31, 2014	1,724			$	18.5		3.31	$	12,884
	Granted	—			$	—
	Exercised	—			$	—			$	—
	Cancelled	(125	)		$	22.66
	Balance outstanding at March 31, 2015	1,599			$	18.17		3.12	$	80
	Vested and expected to vest at March 31, 2015	1,571			$	18.08		3.09	$	80
	Exercisable at March 31, 2015	1,233			$	17.01		2.68	$	80
	-1	The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2014 and March 31, 2015 and the exercise price of in-the-money options as of those dates.
Schedule Of Restricted Stock Unit Activity Under Stock Plans	The following table summarizes restricted stock unit activity, including performance-based and market-based restricted stock unit activity, under the Stock Plans (in thousands, except per share amounts and weighted average remaining contractual life data):
		Number of Restricted Stock Units (1)			Weighted-Average Grant Date Fair Value			Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (2)
	Balance outstanding as of December 31, 2014	873			$	30.86		2.52	$	21,753
	Granted	200			$	6.69
	Vested	(124	)		$	17.95
	Cancelled	(28	)		$	30.56
	Balance outstanding as of March 31, 2015	921			$	27.37		2.93	$	8,642
	-1	Includes certain restricted stock units with both service and performance-based or market-based vesting criteria granted to our executive officers.
	-2	The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2014 and March 31, 2015 multiplied by the number of restricted stock units outstanding as of December 31, 2014 and March 31, 2015, respectively.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
		Three Months Ended March 31,
		2015
	Expected term	2.59 years
	Expected volatility	64.7		%
	Expected dividend yield	—		%
	Risk-free interest rate	1.13		%
	Weighted-average fair value	$	6.69
Schedule Of Stock-Based Compensation Expense	The following table summarizes stock-based compensation expense recorded during the three months ended March 31, 2014 and 2015 (in thousands):
		Three Months Ended March 31,
		2014				2015
	Common stock options	$	642			$	462
	Restricted stock units	1,803				1,569
	Total stock-based compensation expense	$	2,445			$	2,031
	The following table summarizes stock-based compensation expense by operating function for the three months ended March 31, 2014 and 2015 (in thousands):
		Three Months Ended March 31,
		2014				2015
	Marketing and advertising	$	657			$	591
	Customer care and enrollment	96				117
	Technology and content	562				435
	General and administrative	1,130				775
	Restructuring charges	—				113
	Total stock-based compensation expense	$	2,445			$	2,031

Income_Taxes_Tables

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Summary Of Provision (Benefit) For Income Taxes And Effective Tax Rate	The following table summarizes our provision for income taxes and our effective tax rates for the three months ended March 31, 2014 and 2015 (in thousands, except effective tax rate):
		Three Months Ended March 31,
		2014			2015
	Income (loss) before provision for income taxes	$	(3,149	)	$	(2,026	)
	Provision (benefit) for income taxes	$	(1,596	)	$	56
	Effective tax rate	50.7		%	(2.8		)%

Net_Income_Per_Share_Tables

Net Income Per Share (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Schedule Of Computation Of Basic And Diluted Net Income (Loss) Per Share	The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share amounts):
		Three Months Ended March 31,
		2014				2015
	Basic and diluted:
	Numerator:
	Net loss allocated to common stock	$	(1,553	)		$	(2,082	)
	Denominator:
	Weighted average number of common stock shares outstanding	18,849				17,844
	Net loss per share—basic and diluted:	$	(0.08	)		$	(0.12	)
Schedule Of Anti-dilutive Shares Excluded From Computation Of Net Income (Loss) Per Share	The number of outstanding weighted average anti-dilutive shares that were excluded from the computation of diluted net loss per share consisted of the following (in thousands):
		Three Months Ended March 31,
		2014			2015
	Common stock options	1,932			1,702
	Restricted stock units	745			618
	Total	2,677			2,320

Geographic_Information_And_Sig1

Geographic Information And Significant Customers (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Schedule Of Long Lived Assets By Geographical Areas	Long-lived assets by geographical area were as follows (in thousands):
		As of			As of
		December 31, 2014			March 31, 2015
	United States	$	39,752		$	36,885
	China	437			459
	Total	$	40,189		$	37,344
Schedule Of Revenue By Major Customers	Carriers representing 10% or more of our total revenue in the three months ended March 31, 2014 and 2015 are presented in the table below:
		Three Months Ended March 31,
		2014		2015
	Humana	26	%	34	%
	WellPoint (1)	11	%	8	%
	UnitedHealthcare (2)	11	%	9	%
	Aetna (3)	11	%	9	%
	(1)Wellpoint also includes other carriers owned by Wellpoint.
	(2)UnitedHealthcare also includes other carriers owned by UnitedHealthcare.
	(3)Aetna also includes other carriers owned by Aetna.

Restructuring_Charges_Tables

Restructuring Charges (Tables)	3 Months Ended
	Mar. 31, 2015
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	The following table summarizes the total cash and non-cash restructuring charges recorded during the three months ended March 31, 2015 (in thousands):
		Three Months Ended March 31, 2015
	Employee termination costs	$	3,734
	Non-cash employee termination costs - stock-based compensation	113
	Facility and other termination costs	636
	Total restructuring charges	$	4,483
	The following table summarizes the restructuring charges liability activity during the three months ended March 31, 2015 (in thousands):
		Three Months Ended March 31, 2015
		Beginning balance		Charges		Payments			Ending balance
	Employee termination costs	$	—	$	3,734	$	(2,567	)	$	1,167
	Facility and other termination costs	—		636		(33		)	603
	Total restructuring liability	$	—	$	4,370	$	(2,600	)	$	1,770
	Less: non-current restructuring charges associated with facilities								(334		)
	Restructuring charges liability - current								$	1,436

Recovered_Sheet1

Summary of Business And Significant Accounting Policies (Narrative) (Details)	Mar. 31, 2015
	state
Accounting Policies [Abstract]
Number of states in which the Company is licensed to market and sell health insurance	50

Balance_Sheet_Accounts_Schedul

Balance Sheet Accounts (Schedule Of Cash And Cash Equivalents) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Cash and Cash Equivalents, at Carrying Value [Abstract]
Cash	$14,742	$15,793
Cash Equivalents, at Carrying Value	24,623	35,622
Total Cash and Cash Equivalents	$39,365	$51,415	$98,228	$107,055

Balance_Sheet_Accounts_Schedul1

Balance Sheet Accounts (Schedule Of Accounts Receivable) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total accounts receivable	$14,614	$8,200
Medicare Renewal Commissions Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total accounts receivable	12,790	355
Accounts Receivable, Other Revenues [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total accounts receivable	1,329	2,462
Other Commissions Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total accounts receivable	$495	$5,383

Stockholders_Equity_Narrative_

Stockholders' Equity (Narrative) (Details) (USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Total grant date fair value of stock options vested	$0.60	$0.50
Total fair value of restricted stock units vested	$1.20	$8.40
Treasury shares held to satisfy tax withholdings	327,947
Treasury stock number of shares held	10,991,835		10,945,607

Stockholders_Equity_Schedule_O

Stockholders' Equity (Schedule Of Activity Under The Plans) (Details)	3 Months Ended
	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant, beginning balance	4,164,000
Restricted stock units granted	-200,000
Restricted stock units cancelled (1)	19,000	[1]
Options cancelled (2)	9,000	[2]
Shares available for grant, ending balance	3,992,000
2006 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options cancelled (2)	116,000
2006 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units cancelled (1)	9,000
[1]	Restricted stock units cancelled does not include 9,000 restricted stock units cancelled under the 2006 Equity Incentive Plan.
[2]	Options cancelled does not include 116,000 stock options cancelled under the 2006 Equity Incentive Plan.

Stockholders_Equity_Schedule_O1

Stockholders' Equity (Schedule Of Option Activity Under Stock Plans) (Details) (USD $)	3 Months Ended		12 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Number of Stock Options
Cancelled	-9,000	[1]
Common Stock Options [Member]
Number of Stock Options
Balance outstanding at December 31, 2014	1,724,000
Granted	0
Exercised	0
Cancelled	-125,000
Balance outstanding at March 31, 2015	1,599,000		1,724,000
Number of Stock Options Vested and expected to vest at March 31, 2015	1,571,000
Number of Stock Options Exercisable at March 31, 2015	1,233,000
Weighted-Average Exercise Price, balance outstanding at December 31, 2014	$18.50
Weighted-Average Exercise Price, Granted	$0
Weighted-Average Exercise Price, Exercised	$0
Weighted-Average Exercise Price, Cancelled	$22.66
Weighted-Average Exercise Price, Balance outstanding at March 31, 2015	$18.17		$18.50
Weighted-Average Exercise Price, Vested and expected to vest at March 31, 2015	$18.08
Weighted-Average Exercise Price, Exercisable at March 31, 2015	$17.01
Weighted-Average Remaining Contractual Life (years), Balance outstanding at December 31, 2014	3 years 1 month 13 days		3 years 3 months 22 days
Weighted-Average Remaining Contractual Life (years), Balance outstanding at March 31, 2015	3 years 1 month 13 days		3 years 3 months 22 days
Weighted-Average Remaining Contractual Life (years), Vested and expected to vest at March 31, 2015	3 years 1 month 3 days
Weighted-Average Remaining Contractual Life (years), Exercisable at March 31, 2015	2 years 8 months 5 days
Aggregate Intrinsic Value, Balance outstanding at December 31, 2014	$12,884	[2]
Aggregate Intrinsic Value, Exercised	0	[2]
Aggregate Intrinsic Value, Balance outstanding at March 31, 2015	80	[2]	12,884	[2]
Aggregate Intrinsic Value, Vested and expected to vest at March 31, 2015	80	[2]
Aggregate Intrinsic Value, Exercisable at March 31, 2015	$80	[2]
[1]	Options cancelled does not include 116,000 stock options cancelled under the 2006 Equity Incentive Plan.
[2]	The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2014 and March 31, 2015 and the exercise price of in-the-money options as of those dates.

Stockholders_Equity_Schedule_O2

Stockholders' Equity (Schedule Of Restricted Stock Unit Activity Under Stock Plans) (Details) (USD $)	3 Months Ended		12 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Number of Restricted Stock Units
Granted	200,000
Cancelled	-19,000	[1]
Restricted Stock [Member]
Number of Restricted Stock Units
Balance outstanding as of December 31, 2014	873,000	[2]
Granted	200,000	[2]
Vested	-124,000	[2]
Cancelled	-28,000	[2]
Balance outstanding as of March 31, 2015	921,000	[2]	873,000	[2]
Weighted-Average Grant Date Fair Value, Balance outstanding as of December 31, 2014	$30.86
Weighted-Average Grant Date Fair Value, Granted	$6.69
Weighted-Average Grant Date Fair Value, Vested	$17.95
Weighted-Average Grant Date Fair Value, Cancelled	$30.56
Weighted-Average Grant Date Fair Value, Balance outstanding as of March 31, 2015	$27.37		$30.86
Weighted-Average Remaining Contractual Life (years), Balance outstanding as of December 31, 2014	2 years 11 months 5 days		2 years 6 months 6 days
Weighted-Average Remaining Contractual Life (years), Balance outstanding as of March 31, 2015	2 years 11 months 5 days		2 years 6 months 6 days
Aggregate Intrinsic Value, Balance outstanding as of December 31, 2014	$21,753	[3]
Aggregate Intrinsic Value, Balance outstanding as of March 31, 2015	$8,642	[3]	$21,753	[3]
[1]	Restricted stock units cancelled does not include 9,000 restricted stock units cancelled under the 2006 Equity Incentive Plan.
[2]	Includes certain restricted stock units with both service and performance-based or market-based vesting criteria granted to our executive officers.
[3]	The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2014 and March 31, 2015 multiplied by the number of restricted stock units outstanding as of December 31, 2014 and March 31, 2015, respectively.

Recovered_Sheet2

Stockholders' Equity (Schedule of Fair Value of Stock Options, Valuation Assumptions) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Expected term	2 years 7 months 2 days
Expected volatility	64.70%
Expected dividend yield	0.00%
Risk-free interest rate	1.13%
Weighted-average fair value	$6.69

Stockholders_Equity_Schedule_O3

Stockholders' Equity (Schedule Of Stock-Based Compensation Expense) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Common stock options	$462	$642
Restricted stock units	1,569	1,803
Total stock-based compensation expense	$2,031	$2,445

Stockholders_Equity_Schedule_O4

Stockholders' Equity (Schedule Of Stock-Based Compensation Expense By Operating Function) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Component Of Stock Based Compensation Expense [Line Items]
Total Stock-Based Compensation Expense	$2,031	$2,445
Marketing and Advertising Expense [Member]
Component Of Stock Based Compensation Expense [Line Items]
Total Stock-Based Compensation Expense	591	657
Customer Care And Enrollment Expense [Member]
Component Of Stock Based Compensation Expense [Line Items]
Total Stock-Based Compensation Expense	117	96
Technology And Content Expense [Member]
Component Of Stock Based Compensation Expense [Line Items]
Total Stock-Based Compensation Expense	435	562
General and Administrative Expense [Member]
Component Of Stock Based Compensation Expense [Line Items]
Total Stock-Based Compensation Expense	775	1,130
Restructuring Charges [Member]
Component Of Stock Based Compensation Expense [Line Items]
Total Stock-Based Compensation Expense	$113	$0

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Tax Disclosure [Abstract]
Income (loss) before provision (benefit) for income taxes	($2,026,000)	($3,149,000)
Income Tax Expense (Benefit)	56,000	-1,596,000
Effective tax rate	-2.80%	50.70%
Increase in additional paid-in capital related to excess federal and state tax benefits		$3,200,000

Net_Income_Per_Share_Schedule_

Net Income Per Share (Schedule Oof Computation Of Basic And Diluted Net Income (Loss) Per Share) (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share [Abstract]
Net income (loss) allocated to common stock	($2,082)	($1,553)
Net weighted average number of common stock shares outstanding	17,844	18,849
Net income (loss) per share-basic	($0.12)	($0.08)

Net_Income_Per_Share_Schedule_1

Net Income Per Share (Schedule Of Anti-Dilutive Shares Excluded From Computation Of Net Income Per Share) (Details)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	2,320,000	2,677,000
Common Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	1,702,000	1,932,000
Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	618,000	745,000

Geographic_Information_And_Sig2

Geographic Information And Significant Customers (Details) (USD $)	3 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Concentration Risk [Line Items]
Accounts receivable	14,614		8,200
Commission Revenue [Member] | Major Medical Individual And Family Insurance Plans [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	38.00%	60.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Number of significant customers	2		3
Accounts Receivable [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	62.00%		30.00%
Accounts Receivable [Member] | Customer Two [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	10.00%		17.00%
Accounts Receivable [Member] | Concentration Three [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			14.00%

Geographic_Information_And_Sig3

Geographic Information And Significant Customers (Schedule Of Long Lived Assets By Geographical Areas) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Long-lived assets	$37,344	$40,189
UNITED STATES
Long-lived assets	36,885	39,752
CHINA
Long-lived assets	$459	$437

Geographic_Information_And_Sig4

Geographic Information And Significant Customers (Schedule Of Revenue By Major Customers) (Details) (Sales [Member])	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Humana [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	34.00%		26.00%
WellPoint [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	8.00%	[1]	11.00%	[1]
UnitedHealthcare [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	9.00%	[2]	11.00%	[2]
Aetna [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	9.00%	[3]	11.00%	[3]
[1]	Wellpoint also includes other carriers owned by Wellpoint.
[2]	UnitedHealthcare also includes other carriers owned by UnitedHealthcare.
[3]	Aetna also includes other carriers owned by Aetna.

Restructuring_Charges_Narrativ

Restructuring Charges (Narrative) (Details) (USD $)	3 Months Ended		1 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015
			position
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$4,483	$0
Employee Termination Benefits and Related Costs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	3,900
Facility and Other Termination Costs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$636
UNITED STATES
Restructuring Cost and Reserve [Line Items]
Number of positions eliminated			160
Number of positions eliminated, period percent			15.00%

Restructuring_Charges_Restruct

Restructuring Charges (Restructuring Activities) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$4,483	$0
Employee Termination Costs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	3,734
Non-cash Employee Termination Costs - Stock-based Compensation [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	113
Facility and Other Termination Costs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$636

Restructuring_Charges_Liabilit

Restructuring Charges (Liability Activities) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Restructuring Reserve [Roll Forward]
Beginning balance	$0
Charges	4,370,000
Payments	-2,600,000
Ending balance	1,770,000
Less: non-current restructuring charges associated with facilities	-334,000
Restructuring charges liability - current	1,436,000
Employee Termination Costs [Member]
Restructuring Reserve [Roll Forward]
Beginning balance	0
Charges	3,734,000
Payments	-2,567,000
Ending balance	1,167,000
Facility and Other Termination Costs [Member]
Restructuring Reserve [Roll Forward]
Beginning balance	0
Charges	636,000
Payments	-33,000
Ending balance	$603,000

Commitments_and_Contingencies_1

Commitments and Contingencies (Details)	Mar. 10, 2015
	class_action_lawsuit
Commitments and Contingencies Disclosure [Abstract]
Number of class action lawsuits filed against Company	2